DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹2,191 Cr |
| Mar2024 | ₹1,600 Cr |
| Mar2023 | ₹1,824 Cr |
| Mar2022 | ₹2,960 Cr |
| Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,191 Cr | 36.94 | |
| Mar2024 | ₹1,600 Cr | -12.28 | |
| Mar2023 | ₹1,824 Cr | -38.39 | |
| Mar2022 | ₹2,960 Cr | 49.19 | |
| Mar2021 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹183,780.4 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹101,634.0 Cr | 1.4% | 15.8% | -2.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.4% |
11% |
11.5% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses